IGFLR1
gene geneOn this page
Also known as FLJ22573
Summary
IGFLR1 (IGF like family receptor 1, HGNC:23620) is a protein-coding gene on chromosome 19q13.12, encoding IGF-like family receptor 1 (Q9H665). Probable cell membrane receptor for the IGF-like family proteins.
Located in nucleoplasm and plasma membrane.
Source: NCBI Gene 79713 — RefSeq curated summary.
At a glance
- GWAS associations: 4
- Clinical variants (ClinVar): 124 total
- Druggable target: yes
- MANE Select transcript:
NM_024660
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:23620 |
| Approved symbol | IGFLR1 |
| Name | IGF like family receptor 1 |
| Location | 19q13.12 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ22573 |
| Ensembl gene | ENSG00000126246 |
| Ensembl biotype | protein_coding |
| OMIM | 614143 |
| Entrez | 79713 |
Gene structure
Transcript identifiers
Ensembl transcripts: 27 — 23 protein_coding, 2 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined, 1 retained_intron
ENST00000246532, ENST00000586140, ENST00000587101, ENST00000588018, ENST00000588992, ENST00000589175, ENST00000591277, ENST00000591748, ENST00000592537, ENST00000592693, ENST00000592889, ENST00000871289, ENST00000871290, ENST00000871291, ENST00000871292, ENST00000871293, ENST00000871294, ENST00000871295, ENST00000871296, ENST00000871297, ENST00000929955, ENST00000929957, ENST00000966824, ENST00000966825, ENST00000966826, ENST00000966827, ENST00000966828
RefSeq mRNA: 5 — MANE Select: NM_024660
NM_001346003, NM_001346004, NM_001346005, NM_001346006, NM_024660
CCDS: CCDS12472, CCDS86751, CCDS86752
Canonical transcript exons
ENST00000246532 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001057198 | 35742396 | 35742452 |
| ENSE00001276829 | 35741024 | 35741223 |
| ENSE00003462473 | 35738801 | 35739626 |
| ENSE00003584571 | 35739710 | 35740088 |
| ENSE00003674314 | 35740380 | 35740564 |
Expression profiles
Bgee: expression breadth ubiquitous, 139 present calls, max score 97.34.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 16.7923 / max 313.6844, expressed in 1606 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 180547 | 11.9302 | 511 |
| 180546 | 2.9273 | 1174 |
| 180545 | 1.8588 | 782 |
| 180544 | 0.0760 | 33 |
Top tissues by expression
139 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| granulocyte | CL:0000094 | 97.34 | gold quality |
| blood | UBERON:0000178 | 95.47 | gold quality |
| monocyte | CL:0000576 | 95.36 | gold quality |
| leukocyte | CL:0000738 | 95.24 | gold quality |
| lymph node | UBERON:0000029 | 93.85 | gold quality |
| vermiform appendix | UBERON:0001154 | 93.58 | gold quality |
| spleen | UBERON:0002106 | 93.23 | gold quality |
| right lobe of liver | UBERON:0001114 | 92.55 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 89.13 | gold quality |
| bone marrow cell | CL:0002092 | 88.24 | gold quality |
| liver | UBERON:0002107 | 87.65 | gold quality |
| bone marrow | UBERON:0002371 | 86.53 | gold quality |
| right adrenal gland | UBERON:0001233 | 85.72 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 85.37 | gold quality |
| small intestine | UBERON:0002108 | 84.30 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 84.15 | gold quality |
| left adrenal gland | UBERON:0001234 | 84.09 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 83.94 | gold quality |
| tonsil | UBERON:0002372 | 83.47 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 83.46 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 82.93 | gold quality |
| gall bladder | UBERON:0002110 | 82.70 | gold quality |
| apex of heart | UBERON:0002098 | 82.21 | gold quality |
| adrenal gland | UBERON:0002369 | 81.81 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 81.67 | gold quality |
| metanephros cortex | UBERON:0010533 | 81.34 | gold quality |
| right coronary artery | UBERON:0001625 | 81.31 | gold quality |
| duodenum | UBERON:0002114 | 81.22 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 81.18 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 81.17 | gold quality |
Single-cell (SCXA)
Detected in 12 experiment(s), a significant marker in 11.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-HCAD-4 | yes | 55.91 |
| E-HCAD-6 | yes | 35.81 |
| E-HCAD-11 | yes | 20.47 |
| E-MTAB-9467 | yes | 16.10 |
| E-CURD-112 | yes | 14.93 |
| E-MTAB-6701 | yes | 14.61 |
| E-MTAB-8410 | yes | 13.11 |
| E-MTAB-9067 | yes | 12.45 |
| E-CURD-122 | yes | 12.39 |
| E-ANND-3 | yes | 8.92 |
| E-CURD-88 | yes | 4.36 |
| E-CURD-95 | no | 278.21 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): STAT1
Literature-anchored findings (GeneRIF, showing 1)
- Murine insulin growth factor-like (IGFL) and human IGFL1 proteins are induced in inflammatory skin conditions and bind to a novel tumor necrosis factor receptor family member, IGFLR1. (PMID:21454693)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | igflr1 | ENSDARG00000091650 |
| mus_musculus | Igflr1 | ENSMUSG00000036826 |
| rattus_norvegicus | Igflr1 | ENSRNOG00000020957 |
Protein
Protein identifiers
IGF-like family receptor 1 — Q9H665 (reviewed: Q9H665)
Alternative names: Transmembrane protein 149, U2 small nuclear RNA auxiliary factor 1-like 4
All UniProt accessions (7): Q9H665, K7EL86, K7EQI5, K7ES44, K7ESC2, S4R3Z9, U3KQL9
UniProt curated annotations — full annotation on UniProt →
Function. Probable cell membrane receptor for the IGF-like family proteins. Binds IGFL1 and IGFL3 with a higher affinity. May also bind IGFL2.
Subcellular location. Cell membrane.
Induction. Up-regulated by the pro-inflammatory cytokine TNFA and in skin upon tissue inflammation.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9H665-1 | 1 | yes |
| Q9H665-2 | 2 |
RefSeq proteins (5): NP_001332932, NP_001332933, NP_001332934, NP_001332935, NP_078936* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR011029 | DEATH-like_dom_sf | Homologous_superfamily |
| IPR042355 | IGFLR1 | Family |
UniProt features (9 total): topological domain 2, signal peptide 1, chain 1, transmembrane region 1, region of interest 1, compositionally biased region 1, splice variant 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9H665-F1 | 72.73 | 0.41 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 220 (showing top):
GSE45365_NK_CELL_VS_CD8_TCELL_DN, MCLACHLAN_DENTAL_CARIES_UP, STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN, GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN, AACYNNNNTTCCS_UNKNOWN, CREBP1_Q2, GGGTGGRR_PAX4_03, HATADA_METHYLATED_IN_LUNG_CANCER_DN, CREB_Q4, GATA3_01, ATF1_Q6, REACTOME_MRNA_3_END_PROCESSING, REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA, HNF4_DR1_Q3
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (3): nucleoplasm (GO:0005654), plasma membrane (GO:0005886), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| binding | 1 |
| nuclear lumen | 1 |
| membrane | 1 |
| cell periphery | 1 |
Protein interactions and networks
STRING
1530 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| IGFLR1 | IGFL1 | Q6UW32 | 615 |
| IGFLR1 | MDFIC2 | A0A1B0GVS7 | 516 |
| IGFLR1 | IGFL3 | Q6UXB1 | 505 |
| IGFLR1 | NRDE2 | Q9H7Z3 | 461 |
| IGFLR1 | HBM | Q6B0K9 | 447 |
| IGFLR1 | IL18BP | O95998 | 418 |
| IGFLR1 | QRFPR | Q96P65 | 405 |
| IGFLR1 | CCDC160 | A6NGH7 | 389 |
| IGFLR1 | RBM42 | Q9BTD8 | 378 |
| IGFLR1 | FAM174C | Q9BVV8 | 366 |
| IGFLR1 | SLC25A53 | Q5H9E4 | 363 |
| IGFLR1 | LIN37 | Q96GY3 | 360 |
| IGFLR1 | IRAK1BP1 | Q5VVH5 | 338 |
| IGFLR1 | SHISAL1 | Q3SXP7 | 330 |
| IGFLR1 | CDK9 | P50750 | 326 |
IntAct
9 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| IGFL1 | IGFLR1 | psi-mi:“MI:0915”(physical association) | 0.620 |
| IGFLR1 | IGFL1 | psi-mi:“MI:0403”(colocalization) | 0.620 |
| IGFLR1 | IGFL1 | psi-mi:“MI:0915”(physical association) | 0.620 |
| N | NOP56 | psi-mi:“MI:0914”(association) | 0.530 |
| IGFLR1 | IGFL2 | psi-mi:“MI:0915”(physical association) | 0.400 |
| IGFL3 | IGFLR1 | psi-mi:“MI:0915”(physical association) | 0.400 |
ESM2 similar proteins: A0A5F4BST2, A5PJC7, A8MWV9, D3ZZP4, O14836, P0CAN6, P11911, P11912, P14753, Q01114, Q07303, Q13113, Q2KI80, Q2KL21, Q3TS39, Q3URD2, Q4V9L6, Q5F267, Q5FVJ4, Q5FVQ7, Q5RA41, Q5T1S8, Q6P9G4, Q6UWJ8, Q6UX34, Q80VJ8, Q810F0, Q86XR5, Q8BRJ3, Q8BX43, Q8K064, Q8K5A9, Q8N112, Q8N4K4, Q8N6L0, Q8NBR0, Q8NC24, Q8QZT4, Q8R138, Q923S2
Diamond homologs: A5PJC7, Q3U4N7, Q9H665
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
124 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 95 |
| Likely benign | 15 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
928 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:35739622:CAGTT:C | acceptor_gain | 1.0000 |
| 19:35741133:C:CT | acceptor_gain | 1.0000 |
| 19:35741234:C:CT | acceptor_gain | 1.0000 |
| 19:35741235:G:T | acceptor_gain | 1.0000 |
| 19:35741243:C:CT | acceptor_gain | 1.0000 |
| 19:35741244:G:T | acceptor_gain | 1.0000 |
| 19:35739624:GTT:G | acceptor_gain | 0.9900 |
| 19:35739625:TTCTG:T | acceptor_loss | 0.9900 |
| 19:35739626:TC:T | acceptor_loss | 0.9900 |
| 19:35739627:C:CC | acceptor_gain | 0.9900 |
| 19:35739627:CTG:C | acceptor_loss | 0.9900 |
| 19:35739627:CTGGA:C | acceptor_loss | 0.9900 |
| 19:35739628:T:A | acceptor_loss | 0.9900 |
| 19:35741016:ATTCT:A | donor_loss | 0.9900 |
| 19:35741018:TCTCA:T | donor_loss | 0.9900 |
| 19:35741020:T:TC | donor_loss | 0.9900 |
| 19:35741021:C:CC | donor_loss | 0.9900 |
| 19:35741021:C:CG | donor_loss | 0.9900 |
| 19:35741022:AC:A | donor_gain | 0.9900 |
| 19:35741023:C:CT | donor_loss | 0.9900 |
| 19:35741023:CC:C | donor_gain | 0.9900 |
| 19:35741139:C:CT | acceptor_gain | 0.9900 |
| 19:35741227:CA:C | acceptor_gain | 0.9900 |
| 19:35741229:C:CC | acceptor_gain | 0.9900 |
| 19:35741230:T:C | acceptor_gain | 0.9900 |
| 19:35741234:C:T | acceptor_gain | 0.9900 |
| 19:35741247:C:CT | acceptor_gain | 0.9900 |
| 19:35739623:AGTT:A | acceptor_gain | 0.9800 |
| 19:35739625:TT:T | acceptor_gain | 0.9800 |
| 19:35739708:ACC:A | donor_gain | 0.9800 |
AlphaMissense
2228 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:35740555:A:C | F56C | 0.995 |
| 19:35740554:G:C | F56L | 0.993 |
| 19:35740554:G:T | F56L | 0.993 |
| 19:35740556:A:G | F56L | 0.993 |
| 19:35739465:A:G | W295R | 0.992 |
| 19:35739465:A:T | W295R | 0.992 |
| 19:35739491:G:T | A286D | 0.992 |
| 19:35741085:C:A | W32C | 0.992 |
| 19:35741085:C:G | W32C | 0.992 |
| 19:35739560:A:G | L263P | 0.991 |
| 19:35739454:A:C | F298L | 0.989 |
| 19:35739454:A:T | F298L | 0.989 |
| 19:35739456:A:G | F298L | 0.989 |
| 19:35740555:A:G | F56S | 0.989 |
| 19:35740543:C:G | C60S | 0.985 |
| 19:35740544:A:T | C60S | 0.985 |
| 19:35741043:G:C | F46L | 0.985 |
| 19:35741043:G:T | F46L | 0.985 |
| 19:35741045:A:G | F46L | 0.985 |
| 19:35741104:C:G | C26S | 0.984 |
| 19:35741105:A:T | C26S | 0.984 |
| 19:35739463:C:A | W295C | 0.983 |
| 19:35739463:C:G | W295C | 0.983 |
| 19:35739545:T:C | D268G | 0.983 |
| 19:35739353:A:T | L332H | 0.982 |
| 19:35739566:T:A | E261V | 0.982 |
| 19:35741104:C:T | C26Y | 0.982 |
| 19:35739560:A:T | L263Q | 0.981 |
| 19:35739503:G:A | T282I | 0.979 |
| 19:35739545:T:A | D268V | 0.979 |
dbSNP variants (sampled 300 via entrez): RS1000971736 (19:35740802 G>A,T), RS1001911955 (19:35740214 G>A,T), RS1002970843 (19:35739116 C>G,T), RS1003090496 (19:35743423 G>A), RS1003120808 (19:35744197 G>A,T), RS1003632561 (19:35739852 T>A), RS1004310372 (19:35740248 C>T), RS1004951866 (19:35741715 G>A), RS1005034610 (19:35744258 C>T), RS1005277772 (19:35739501 G>A,C,T), RS1006039121 (19:35742666 C>A,T), RS1007034807 (19:35741480 C>T), RS1007555937 (19:35739372 C>G), RS1008033533 (19:35743039 G>A,C), RS1008111448 (19:35740628 C>A,G)
Disease associations
OMIM: gene MIM:614143 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
4 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST006585_1596 | Blood protein levels | 4.000000e-69 |
| GCST010002_54 | Refractive error | 1.000000e-10 |
| GCST010703_277 | Brain morphology (MOSTest) | 2.000000e-15 |
| GCST90002404_531 | Red cell distribution width | 1.000000e-15 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004346 | neuroimaging measurement |
| EFO:0009188 | Red cell distribution width |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL2029192 (SINGLE PROTEIN)
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
24 total (human), top 24 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Nickel | increases expression | 2 |
| triphenyl phosphate | affects expression | 1 |
| terbufos | decreases methylation | 1 |
| arsenite | affects expression | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | decreases expression | 1 |
| 2,3-bis(3’-hydroxybenzyl)butyrolactone | affects cotreatment, increases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| perfluorooctane sulfonic acid | increases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| jinfukang | increases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Calcitriol | increases expression | 1 |
| Coumestrol | affects cotreatment, increases expression | 1 |
| Dexamethasone | increases expression | 1 |
| Fonofos | decreases methylation | 1 |
| Estradiol | decreases expression | 1 |
| Hydrogen Peroxide | affects expression | 1 |
| Parathion | decreases methylation | 1 |
| Smoke | decreases expression | 1 |
| Urethane | decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Aflatoxin B1 | decreases expression | 1 |
| Antirheumatic Agents | decreases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
ChEMBL screening assays
3 unique, capped per target: 3 binding
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL2033413 | Binding | Inhibition of IGFR1 in human HEK293 cells after 1 hr by competition binding assay | Identification of 1-(3-(6,7-dimethoxyquinazolin-4-yloxy)phenyl)-3-(5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-3-yl)urea hydrochloride (CEP-32496), a highly potent and orally efficacious inhibitor of V-RAF murine sarcoma viral oncogene homologue B1 (BRAF) V600E. — J Med Chem |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.